Molecular Profiling & Diagnostics at Single Cell Level.
CTC Enumeration
After ApoStreamTM enrichment, CTCs can be further immunophenotyped by quantitative image analysis using ApoCell’s proprietary Laser Scanning Cytometry (LSC). Preliminary data indicate that ApoStreamTM technology is capable of isolating thousands of CTCs from advanced prostate and lung cancer patients. ApoCell is now using this technology to capture and identify CTCs from non-epithelial based cancers as well as increase the number of CTCs recovered from epithelial based cancers.

Â
CTC Protein Analysis
ApoStreamTM technology provides unique advantages over immuno-labeling based approaches for isolating CTCs from a wide variety of cancers, especially in a viable state, can facilitate research into the molecular underpinning of disease condition and further enable personalized therapy.
Functional Biomarkers
Single Cell Protein Analysis
Â
CTC Molecular Characterization
ApoStreamTM technology has been proved to be superior to current immunomagnetic CTC enrichment methods in terms of substantially increased sensitivity and greater yields of CTCs for downstream molecular analysis.